Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis

被引:8
|
作者
Yin, Hanlin [1 ]
Distler, Oliver [2 ]
Shen, Lichong [1 ]
Xu, Xiaojiang [3 ]
Yuan, Ye [4 ,5 ]
Li, Rui [1 ]
Liu, Bei [1 ]
Li, Qianqian [1 ]
Huang, Qianru [1 ,6 ]
Xie, Feng [1 ,6 ]
Zhang, Zhiliang [1 ,7 ]
Liang, Rui [1 ,6 ]
Dai, Xueyu [6 ]
Chen, Xiaoxiang [1 ,8 ]
Li, Bin [6 ]
Yan, Qingran [1 ]
Lu, Liangjing [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai, Peoples R China
[2] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[3] Tulane Univ, Dept Pathol & Lab Med, Sch Med, New Orleans, LA USA
[4] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai, Peoples R China
[5] Minist Educ China, Key Lab Syst Control & Informat Proc, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Med,Dept Thorac Surg,Dept Immunol & Microbiol, Dept Resp & Crit Care Med,Shanghai Inst Immunol, Ruijin Hosp,Jiading New Town Ctr,Ctr Immune Relate, Shanghai, Peoples R China
[7] Ningbo Hangzhou Bay Hosp, Dept Plast & Aesthet Surg, Ningbo, Zhejiang, Peoples R China
[8] Nantong Univ, Nantong Hosp,Sch Med, Nantong Peoples Hosp 1,Shanghai Jiao Tong Univ, Dept Rheumatol,Affiliated Hosp 2,Renji Hosp, Nantong 226006, Peoples R China
关键词
GENE-EXPRESSION; DOUBLE-BLIND; SKIN; ACTIVATION; INDUCTION; ALPHA; CELLS; ASSOCIATION; SCLERODERMA; RECEPTOR;
D O I
10.1002/art.42662
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveInterferon (IFN)-1 signatures are a hallmark of patients with systemic sclerosis (SSc). However, its significance in clinical stratification and contribution to deterioration still need to be better understood.MethodsFor hypothesis generation, we performed single-cell RNA sequencing (scRNA-seq) on skin biopsies (four patients with SSc and two controls) using the BD Rhapsody platform. Two publicly available data sets of skin scRNA-seq were used for validation (GSE138669: 12 patients with diffuse cutaneous SSc [dcSSc] and 10 controls; GSE195452: 52 patients with dcSSc and 41 patients with limited cutaneous SSc [lcSSc] and 54 controls). The IFN-1 signature was mapped, functionally investigated in a bleomycin plus IFN alpha-2 adenovirus-associated virus (AAV)-induced model and verified in an SSc cohort (n = 61).ResultsThe discovery and validation data sets showed similar findings. Endothelial cells (ECs) had the most prominent IFN-1 signature among dermal nonimmune cells. The EC IFN-1 signature was increased both in patients with SSc versus controls and in patients with dcSSc versus those with lcSSc. Among EC subclusters, the IFN-1 signature was statistically higher in the capillary ECs of patients with dcSSc, which was higher than those in patients with lcSSc, which in turn was higher than those in healthy controls (HCs). Endothelial-to-mesenchymal transition (EndoMT) scores increased in parallel. Deteriorated bleomycin-induced dermal fibrosis, EndoMT, and perivascular fibrosis and caused blood vessel loss with EC apoptosis. Vascular myxovirus resistance (MX) 1, an IFN-1 response protein, was significantly increased both in total SSc versus HC skin and in dcSSc versus lcSSc skin. Baseline vascular MX1 performed similarly to skin score in predicting disease progression over 6 to 34 months in total SSc and was superior in the dcSSc subpopulation.ConclusionThe EC IFN-1 signature distinguished SSc skin subtypes and disease progression and may contribute to vasculopathy and fibrosis.image image
引用
收藏
页码:78 / 91
页数:14
相关论文
共 50 条
  • [31] The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis
    Yang, Chenxi
    Lu, Chunxiu
    Pan, Jie
    Zhao, Cheng
    Chen, Zhanrui
    Qin, Fang
    Wen, Jing
    Wei, Wanling
    Lei, Ling
    RHEUMATOLOGY, 2023, 62 (10) : 3439 - 3447
  • [32] Myocardial Fibrosis in Systemic Sclerosis, Progression and Response to Therapy Measured by Cardiovascular Magnetic Resonance
    Lee, Daniel C.
    Shah, Sanjiv J.
    Benefield, Brandon C.
    Carr, James C.
    Freed, Benjamin H.
    Burns, Carol Ann
    Burt, Richard K.
    CIRCULATION, 2017, 136
  • [33] Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus
    Thanarajasingam, Uma
    Muppirala, Anoohya N.
    Jensen, Mark A.
    Ghodke-Puranik, Yogita
    Dorschner, Jessica M.
    Vsetecka, Danielle M.
    Amin, Shreyasee
    Makol, Ashima
    Ernste, Floranne
    Osborn, Thomas
    Moder, Kevin
    Chowdhary, Vaidehi
    Niewold, Timothy B.
    ACR OPEN RHEUMATOLOGY, 2019, 1 (08) : 499 - 506
  • [34] MXA IS A CLINICALLY APPLICABLE BIOMARKER FOR TYPE I INTERFERON ACTIVATION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS
    Huijser, Erika
    van Helden-Meeuwsen, C. G.
    Groot, Noortje
    Bodewes, Iris L. A.
    Wahadat, M. Javad
    Schreurs, MarcoWj
    van Daele, Paul L. A.
    Dalm, Virgil Ash
    van Laar, Jan
    van Hagen, P. Martin
    Waris, Matti
    Kamphuis, Sylvia
    Versnel, Marjan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1429 - 1429
  • [35] MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis
    Huijser, Erika
    van Helden-Meeuwsen, Cornelia G.
    Groot, Noortje
    Bodewes, Iris L. A.
    Wahadat, M. Javad
    Schreurs, Marco W. J.
    van Daele, Paul L. A.
    Dalm, Virgil A. S. H.
    van Laar, Jan A. M.
    van Hagen, P. Martin
    Waris, Matti
    Kamphuis, Sylvia
    Versnel, Marjan A.
    RHEUMATOLOGY, 2019, 58 (07) : 1302 - 1303
  • [36] Serum Markers Of Disease Progression In Idiopathic Pulmonary Fibrosis And In Interstitial Lung Disease Associated With Systemic Sclerosis
    de Lauretis, A.
    Pantelidis, P.
    Sestini, P.
    Goh, N.
    Hoyles, R.
    Zappala, C.
    Denton, C.
    Abraham, D.
    Kelleher, P.
    Du Bois, R. M.
    Hansell, D.
    Wells, A.
    Renzoni, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [37] Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis
    Noda, Shinji
    Asano, Yoshihide
    Takahashi, Takehiro
    Akamata, Kaname
    Aozasa, Naohiko
    Taniguchi, Takashi
    Ichimura, Yohei
    Toyama, Tetsuo
    Sumida, Hayakazu
    Kuwano, Yoshihiro
    Yanaba, Koichi
    Tada, Yayoi
    Sugaya, Makoto
    Kadono, Takafumi
    Sato, Shinichi
    RHEUMATOLOGY, 2013, 52 (05) : 790 - 799
  • [38] Exaggerated molecular response to injections of interferon-β predicts disease activity in multiple sclerosis
    Rudick, Richard A.
    Rani, M. R. Sandhya
    Xu, Yaomin
    Lee, Jar-Chi
    Na, Jie
    Shrock, Jennifer
    Josyula, Anupama
    Fisher, Elizabeth
    Ransohoff, Richard M.
    CYTOKINE, 2010, 52 (1-2) : 100 - 100
  • [39] Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease
    Takei, Reoto
    Arita, Machiko
    Kumagai, Shogo
    Ito, Yuhei
    Tokioka, Fumiaki
    Koyama, Takashi
    Saito, Rintaro
    Nishimura, Keisuke
    Tokumasu, Hironobu
    Ishida, Tadashi
    RESPIROLOGY, 2018, 23 (04) : 385 - 391
  • [40] RADIOGRAPHIC FIBROSIS SCORE PREDICTS SURVIVAL IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Takei, Reoto
    Arita, Machilko
    Kumagai, Shogo
    Ito, Yuhei
    Noyama, Maki
    Tokioka, Fumiaki
    Koyama, Takashi
    Saito, Rintaro
    Nishimura, Keisuke
    Tokumasu, Hironobu
    Ishida, Tadashi
    RESPIROLOGY, 2017, 22 : 257 - 257